Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence.

In conclusion, gemcitabine intravesical chemotherapy group was significantly related to a lower rate of recurrence, progression and treatment failure. Gemcitabine could be considered as a choice for these patients who are not suitable for BCG.